Dr. Reddy's Laboratories Ltd Common Stock vs ProShares Ultra Semiconductors — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while ProShares Ultra Semiconductors trades at $80.8 (market cap $2.80B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 3.9× ProShares Ultra Semiconductors's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while ProShares Ultra Semiconductors pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and ProShares Ultra Semiconductors for 30 Days on average.
| RDY | USD | |
|---|---|---|
Market Cap | $10.78B | $2.80B |
Volume | 2,724,343 | 467,963 |
Sector | Health | Leveraged / Inverse |
52-Week High | $15.38 | $113.53 |
52-Week Low | $11.38 | $43.19 |
Typical Hold Time | 0 Days | 30 Days |
Enterprise Value | $10.68B | — |
Dividend Yield | 0.65% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USD stock trades at $91.26 with a modest 0.26% daily gain, showing neutral momentum amid bearish technical signals. The company declared a $0.13 dividend for H2-2026, payable September 29, 2026. Technical indicators show mixed signals with moving averages bearish but oscillators neutral, while support sits at $90 and resistance at $93.
Fundamental data remains limited with key ratios unavailable, requiring deeper financial review. The stock faces headwinds from bearish technical trends but maintains dividend distribution. Investment appeal hinges on upcoming financial disclosures and market sentiment shifts amid current neutral oscillators.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →